Public Release: 

Patchy distribution of joint inflammation resolved

VIB (the Flanders Institute for Biotechnology)

Chronic inflammatory rheumatic diseases such as rheumatoid arthritis (RA) and spondylo-arthritis (SpA) are chronic disabling diseases that have a poor outcome on loco-motoric function, if left untreated. RA en SpA affect each about 1% of the population. The reason why certain joints are more affected than others has been a longstanding question, resolved by Isabelle Cambré and Prof. Dirk Elewaut from the VIB-UGent Center for Inflammation Research who published their results in Nature Communications

They found that biomechanical forces are key drivers behind this observation. By studying the inflammation induced bone erosions in detail they identified certain hot spots in the musculoskeletal system where joint inflammation and erosions are more likely to occur. These sites are especially sensitive to mechanical loading and explain the clinical pattern of joint involvement described in human patients.

The team also discovered the underlying mechanisms, which involves release of certain inflammatory mediators, like chemokines, by joint resident cells in response to mechanical stress. This in turn leads to recruitment of certain white blood subsets, classical monocytes, into mechanically stressed regions where they mediate inflammation and subsequently tissue damage such as erosions.

Isabelle Cambré (VIB-UGent): "Our results explain to a large degree the patchy nature of joint inflammation in human arthritis and the clinical pattern of joint involvement." We are currently trying to unravel the underlying pathways driving this inflammation: we are excited about this as this is potentially a new area of research at the intersection of mechanobiology and inflammation.

###

Publication

Mechanical strain determines the site-specific localization of inflammation and tissue damage in arthritis, Cambré et al., Nature Communications 2018

Questions from patients

A breakthrough in research is not the same as a breakthrough in medicine. The realizations of VIB researchers can form the basis of new therapies, but the development path still takes years. This can raise a lot of questions. That is why we ask you to please refer questions in your report or article to the email address that VIB makes available for this purpose: patienteninfo@vib.be">patienteninfo@vib.be. Everyone can submit questions concerning this and other medically-oriented research directly to VIB via this address.

Funding

Fonds Wetenschappelijk Onderzoek-Vlaanderen (FWO), Fonds voor Wetenschappelijk Reuma Onderzoek (FWRO)

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.